Gattefossé USA and Gattefossé Canada announce their partnership with Société Industrielle des Oléagineux (SIO), a subsidiary of Archer Daniels Midland Company (ADM), to bring highly refined USP/NF grade injectable oils to the North American pharmaceutical product development market.
SIO’s Refined Soybean Oil IV, Refined Sesame Oil IV, and Refined Olive Oil IV are currently referenced in parenteral lipid emulsions and a variety of pharmaceutical applications.
Responding to the pharmaceutical industry’s needs, notably availability of excipients in drug development formulations, Gattefossé is pleased to offer these USP/NF grade high purity oils in North America.
“As a well-known supplier of lipid-based pharmaceutical excipients, Gattefossé’s philosophy fits well with that of SIO. Including highly purified oils to our North American portfolio allows us to offer a wider range of products to our pharmaceutical customers, especially those formulating for parenteral administration,” states Eric Brun, President and CEO of Gattefossé USA & Canada.